AbstractSpaceflight personnel need treatment options that would enhance survival from radiation and would not disrupt task performance. Doses of prophylactic or therapeutic agents known to induce significant short-term (30-day) survival with minimal behavioral (locomotor) changes were used for 180-day survival studies. In protection studies, groups of mice were treated with the phosphorothioate WR-151327 (200 mg/kg, 25% of the LD10) or the immunomodulator, synthetic trehalose dicorynomycolate (S-TDCM; 8 mg/kg), before lethal irradiation with reactor-generated fission neutrons and γ-rays (n/γ = 1) or 60Co γ-rays. In therapy studies, groups of mice received either S-TDCM, the antimicrobial ofloxacin, or S-TDCM plus ofloxacin after irradiation. For WR-151327 treated-mice, survival at 180 days for n/γ = 1 and γ-irradiated mice was 90% and 92%, respectively; for S-TDCM (protection), 57% and 78%, respectively; for S-TDCM (therapy), 20% and 25%, respectively; for ofloxacin, 38% and 5%, respectively; for S-TDCM combined with ofloxacin, 30% and 30%, respectively; and for saline, 8% and 5%, respectively. Ofloxacin or combined ofloxacin and S-TDCM increased survival from the gram-negative bacterial sepsis that predominated in n/γ = 1) irradiated mice. The efficacies of the treatments depended on radiation quality, treatment agent and its mode of use, and microflora of the host.
Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin
Advances in Space Research ; 14 , 10 ; 583-586
1994-01-01
4 pages
Article (Journal)
Electronic Resource
English
Single Dose Ofloxacin in the Eradication of Pharyngeal Carriage of Neisseria meningitidis
British Library Conference Proceedings | 1995
|Long Survival-Rate in Patients with Esophygus Cancer Treated with PDT
British Library Conference Proceedings | 1994
|Increased survival of Penaeus monodon larvae treated with Vibrio harveyi bacterin
British Library Conference Proceedings | 1998
|